Why Kestra Medical Technologies, Ltd.’s (KMTS) Stock Is Up 6.08%
As of Monday, July 27, Kestra Medical Technologies, Ltd.’s KMTS share price has surged by 6.08%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Stock Evaluator: Kestra Medical Technologies, Ltd. (KMTS)
Kestra Medical Technologies, Ltd. KMTS
$22.83
-0.32
-1.38%
July 31, 2026 4:00:00 PM
EST
Volume: 277,949
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.
Commentary & Analysis
Why Kestra Medical Technologies, Ltd.’s (KMTS) Stock Is Down 8.56%
As of Wednesday, July 15, Kestra Medical Technologies, Ltd.’s KMTS share price has dipped by 8.56%, which has investors questioning if this is right time to buy.Rosalio Madrigal
What You Need to Know About Kestra Medical Technologies, Ltd.'s Q1 Earnings
Kestra Medical Technologies, Ltd.'s fiscal Q1 earnings report was released on Tuesday, July 14. Let's dive in to see if (KMTS) missed or beat analyst's expectations.Jenna Brashear
Why Kestra Medical Technologies, Ltd.’s (KMTS) Stock Is Up 8.75%
As of Wednesday, July 01, Kestra Medical Technologies, Ltd.’s KMTS share price has surged by 8.75%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Kestra Medical Technologies, Ltd.’s (KMTS) Stock Is Up 6.95%
As of Friday, June 26, Kestra Medical Technologies, Ltd.’s KMTS share price has surged by 6.95%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,356.7 | $334.8 | 49% |
|
| Shares Out (Mil) | 58.4 | 41.7 | 51% |
|
| Institutional Ownership | 97.9% | 77.3% | 76% |
|
| Float (Mil) | 32.6 | 34.7 | 38% |
|
| Beta | na | 0.86 | na |
|
| Avg Daily Volume (000s) | 313 | 266 | 51% |
|
| Price Change (52-week) |
40.3% | 60.7% | 76% |
|
| Growth | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (34.9%) | (5.8%) | 11% |
|
| EPS (5yr) | 61.3% | 10.7% | 96 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 1.2% | (16.1%) | 66% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.625) | ($2.305) | ($2.020) | |
| Month Ago EPS | ($0.540) | ($2.140) | ($1.410) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 3 | 2 | |
| Three Months Ago EPS | ($0.540) | ($2.140) | ($1.410) | |
| Year/Year Chg | (6.0%) | (5.1%) | (32.7%) | |
| Financials | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $95 | $152 | 26% |
|
| Net Income (TTM) (Mil) | ($132) | ($11) | 9% |
|
| EPS (TTM) | ($2.429) | ($0.500) | 13% |
|
| Operating Cash Flow (TTM) (Mil) | ($82) | ($2) | 7% |
|
| Net Cash Flow (TTM) (Mil) | ($138) | $1 | 12% |
|
| Long-Term Debt (Q1) (Mil) | $47 | $22 | 38% |
|
| Enterprise Value (Q1) (Mil) | $1,212 | $304 | 43% |
|
| Valuation | KMTS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.20 | 2.88 | 79% |
|
| P/E | na | 30.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | KMTS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 51.4% | 59.1% | 63% |
|
| Net Margin | (138.4%) | (7.7%) | 6% |
|
| ROA | (40.2%) | (13.7%) | 14% |
|
| ROE | (56.6%) | (15.9%) | 14% |
|
| Liabilities to Assets | 27.6% | 44.9% | 19% |
|
| F-Score | 4 | 4 | 34% |
|
Kestra Medical Technologies, Ltd. did not pass any screens on 7/30/2026.
